Biotech Stocks Face Big $15B Hit as Vertex, Ionis Skew Flat Weekly Tape
Biotech names Vertex Pharmaceuticals and Ionis Pharmaceuticals slumped after two big setbacks, wiping out about $14.8 billion in market value over the five sessions through Friday. That's going by Friday's share counts and using July 2 and July 10 close, even as a takeover target in the sector almost doubled.
